CRYSTAL STRUCTURE OF HUMAN GTP CYCLOHYDROLASE I

Günter Auerbach(Max Planck Institute of Biochemistry), A. Bacher, Andreas Bracher(Max Planck Institute of Biochemistry), J. Richardson, Markus Gütlich(Max Planck Institute of Biochemistry), Herbert Nar(Boehringer Ingelheim (Germany)), Gerd Bader(Boehringer Ingelheim (Austria)), Malte Fischer(University of Göttingen), M. Neukamm(Max Planck Institute of Biochemistry), Anja Herrmann(Max Planck Institute of Biochemistry), R. Huber(Max Planck Institute of Biochemistry), M. Garrido-Franco(Max Planck Institute of Biochemistry)
Unknown
July 14, 2000
10.2210/pdb1fb1/pdb
Cited by 0

Related Papers

A specific antidote for dabigatran: functional and structural characterization
|Blood|2013|562
Crystal structure analysis of oxidized Pseudomonas aeruginosa azurin at pH 5·5 and pH 9·0
|Journal of Molecular Biology|1991|487
Structure-Based Design of Novel Potent Nonpeptide Thrombin Inhibitors
|Journal of Medicinal Chemistry|2002|454
Biophysics in drug discovery: impact, challenges and opportunities
|Nature Reviews Drug Discovery|2016|383
8-(3-(<i>R</i>)-Aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydropurine-2,6-dione (BI 1356), a Highly Potent, Selective, Long-Acting, and Orally Bioavailable DPP-4 Inhibitor for the Treatment of Type 2 Diabetes
|Journal of Medicinal Chemistry|2007|285